A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

This study has been completed.
Sponsor:
Information provided by:
NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier:
NCT00002210
First received: November 2, 1999
Last updated: June 23, 2005
Last verified: January 1998

November 2, 1999
June 23, 2005
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00002210 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
Phase II Study of the Safety, Tolerance, Pharmacokinetics, and Antiviral Effect of Delavirdine Mesylate (Rescriptor), in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1-Infected Neonates, Infants, and Children

The purpose of this study is to see if it is safe and effective to give delavirdine mesylate (Rescriptor) plus two nucleoside reverse transcriptase inhibitors (NRTIs) to HIV-infected children and babies. This study also examines how the body processes Rescriptor when taken with 2 NRTIs.

Not Provided
Interventional
Phase 2
Primary Purpose: Treatment
HIV Infections
Drug: Delavirdine mesylate
Not Provided
Willoughby R, Watson D, Welliver R. Early use of RESCRIPTOR (delavirdine) in children with HIV. 39th Intersci Conf Antimicrob Agents Chemother. 1999 Sept 26-29 (abstract no 1995)

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
Not Provided
Not Provided

Inclusion Criteria

Patients must have:

  • HIV infection.
  • Plasma HIV-1 levels greater than 10,000 copies/ml.
Both
1 Month to 15 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00002210
228D, 0069
Not Provided
Not Provided
Pharmacia and Upjohn
Not Provided
Not Provided
NIH AIDS Clinical Trials Information Service
January 1998

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP